Streetbeat News

Analyst Ratings

ALVR

CMS

CTSH

EQ

FPI

HBAN

KRTX

MOD

OHI

PAYX

Wall Street analysts have updated their price targets and ratings for several companies. Karuna Therapeutics' target was raised but downgraded to Neutral. AlloVir's target was cut significantly and downgraded to Underperform. Farmland Partners, Huntington Bancshares, Cognizant Technology Solutions, Modine Manufacturing, and CMS Energy had their targets raised with positive ratings. Paychex and Omega Healthcare Investors had their targets cut with neutral and hold ratings, respectively. Equillium's target was slashed but maintained a Buy rating.

Portfolio Pulse from Avi Kapoor

December 26, 2023 | 1:03 pm

MPWR

Rosenblatt analyst Hans Mosesmann maintains a Buy rating on Monolithic Power Systems (MPWR) and increases the price target from $550 to $750.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 1:02 pm

CMS

CMS Energy (NYSE:CMS) has received mixed ratings from 7 analysts in the past three months, with an average 12-month price target of $59.57, down 3.66% from previous estimates. The company faces revenue challenges with a -17.34% decline over 3 months, a below-average net margin of 10.4%, but strong ROE and ROA figures. It also has a high debt-to-equity ratio of 2.22. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance.

Portfolio Pulse from Benzinga Insights

December 26, 2023 | 1:00 pm

HBAN

Huntington Bancshares (NASDAQ:HBAN) received mixed analyst ratings in the past three months, with a recent average 12-month price target of $13.11, up from $12.94. Analysts from firms like Raymond James, RBC Capital, Goldman Sachs, Morgan Stanley, Barclays, JP Morgan, and Citigroup have updated their ratings and price targets, reflecting their views on the company's performance and market conditions. Huntington Bancshares, a regional bank holding company, faces revenue challenges and has a below-average net margin and ROA, but an above-average ROE and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

December 26, 2023 | 1:00 pm

OHI

Truist Securities analyst Michael Lewis has maintained a Hold rating on Omega Healthcare Investors (OHI) and reduced the price target from $34 to $31.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 12:52 pm

CTSH

Wedbush analyst Moshe Katri has maintained an Outperform rating on Cognizant Technology Solutions (CTSH) and increased the price target from $75 to $85.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 12:50 pm

MOD

DA Davidson analyst Matt Summerville has reaffirmed a Buy rating on Modine Manufacturing (NYSE:MOD) and increased the price target from $60 to $80.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 12:48 pm

DNTH

Jefferies analyst Maury Raycroft has initiated coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Buy rating and set a price target of $22.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 12:40 pm

CMS

BMO Capital analyst James Thalacker has maintained an Outperform rating on CMS Energy (NYSE:CMS) and increased the price target from $61 to $64.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 12:30 pm